Prospective real-world data confirm the tolerability of cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study - 2024
Prospective real-world data confirm the tolerability of cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study
Gennigens, Christine; De Ruyter, Vincent; De Sutter, Davidet al.
Gennigens, Christine ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'oncologie médicale
De Ruyter, Vincent; Ipsen, Medical Department, Merelbeke, Belgium
De Sutter, David; Ipsen, Medical Department, Merelbeke, Belgium
Rottey, Sylvie; UZ Gent, Dept. of Medical Oncology, Ghent, Belgium
Langue du document :
Anglais
Titre :
Prospective real-world data confirm the tolerability of cabozantinib in patients with advanced renal cell carcinoma: Interim results of the Belgian REPLICA study
